News
OIG green lights drug manufacturer-sponsored genetic testing program
13 April 2022
On April 11, 2022, the Department of Health and Human Services (HHS) Office of Inspector General (OIG) published Advisory Opinion No. 22-06, concluding that a pharmaceutical...